First human test for new hives drug candidate begins
NCT ID NCT06294288
Summary
This was the first study in humans to test a potential new drug called LP-003, which is being developed for chronic hives. Researchers gave single and then multiple doses to 60 healthy volunteers to check if it was safe and to see how the body processes it. The main goal was to understand the drug's safety profile and how it behaves in the bloodstream before testing it in people with the actual condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SPONTANEOUS URTICARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Shanghai General Hospital
Shanghai, Shanghai Municipality, China
Conditions
Explore the condition pages connected to this study.